Y
Yiming Zhou
Researcher at Shanghai Institute of Technology
Publications - 8
Citations - 89
Yiming Zhou is an academic researcher from Shanghai Institute of Technology. The author has contributed to research in topics: Fagopyrum tataricum & Fagopyrum. The author has an hindex of 4, co-authored 8 publications receiving 63 citations.
Papers
More filters
Journal ArticleDOI
Advance on the benefits of bioactive peptides from buckwheat
TL;DR: The antibacterial, trypsin inhibiting, antitumor, hypocholesterol, hypotensive and antidiabetic effects of buckwheat proteins and their enzyme hydrolysates were summarized and discussed.
Journal ArticleDOI
Early-life food nutrition, microbiota maturation and immune development shape life-long health.
TL;DR: The combined interrelationship between food ingredients nutrition, intestinal microbiota configurations and host system immunity provides new therapeutic targets to treat various kinds of pathogenic inflammations and chronic diseases.
Journal ArticleDOI
The Effect of Tartary Buckwheat Flavonoids in Inhibiting the Proliferation of MGC80-3 Cells during Seed Germination
TL;DR: MTT assay showed that the effect of total flavonoids on human gastric cancer cell line MGC80-3 was significantly changed after EF treatment for different germination days, and the total Flavonoids of tartary buckwheat (BWTF) on the third day had the most obvious inhibitory effect on MGC 80-3.
Journal ArticleDOI
Toward a novel understanding of buckwheat self-defensive strategies during seed germination and preliminary investigation on the potential pharmacological application of its malting products
Xiaoli Zhou,Shaoning Cheng,Yanli Yang,Yiming Zhou,Wen Tang,Xiaojing Zhang,Qing Wang,Zongjie Li +7 more
TL;DR: Through long term evolution, buckwheat had already developed advanced strategies to repair inner injury and to resist the outer environmental risks during seed germination, indicating that the enriched production of flavonoids in the germinating stage might quite possibly be applied in clinical field to deal with lung cancer.
Journal ArticleDOI
A novel buckwheat protein with a beneficial effect in atherosclerosis was purified from fagopyrum tataricum (l.) gaertn.
TL;DR: The isolated buckwheat protein fractions exhibited hypocho- lesterolemic activity in a HepG2 cell model and demonstrated prominent bile acid salt-binding activity in an in vitro assay, and could become a potential candidate in the treatment of atherosclerosis.